Xellar Biosystems
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $72M
Investors
- 13
About Xellar Biosystems
Established in 2021 and based in Boston, US, Beijing Xellar Biosystems Co., doing business as Xellar Biosystems, operates a drug discovery platform that integrates organ chip technology and artificial intelligence. The company established a research and development laboratory in Boston. The co-founder and chief executive officer, Xin Xie, completed post-doctoral research in organ chip and engineered life systems at Harvard University and later worked at TransMedics. The company works with pharmaceutical and biotechnology customers to provide drug discovery services based on organ chip technology and three dimensional cellular models. Its platform integrates microfluidic organ models, high content cell imaging, computer vision, and artificial intelligence to support drug safety assessment, efficacy analysis, and treatment response simulation. The company’s core product is the EPIC technology platform. The company generates revenue from providing artificial intelligence enabled drug discovery services and licensing its proprietary technology platform to pharmaceutical and biotechnology companies. The company plans to use the series A+ fundingto construct its 3D Bio Intelligence platform, deploy automated experimental systems, and develop Virtual Cells and Biological World Models to establish a humanized data infrastructure for drug discovery.
Who invested in Xellar Biosystems
13 investors across 4 rounds
See all investors in Xellar Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xellar Biosystems
Who invested in Xellar Biosystems?
Xellar Biosystems has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xellar Biosystems raised?
Xellar Biosystems has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Xellar Biosystems last raise money?
Xellar Biosystems's most recent round on record is a Series A, in Jun 2026.
What does Xellar Biosystems do?
Established in 2021 and based in Boston, US, Beijing Xellar Biosystems Co.
Where is Xellar Biosystems headquartered?
Xellar Biosystems is headquartered in Boston, US.
Which VCs invest in companies like Xellar Biosystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xellar Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xellar Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.